| Company | Jul 25 | Aug 25 | Sep 25 | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | 12-Mo |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NLST | -6% | +29% | +11% | -32% | -2% | +41% | +35% | +0% | +30% | +49% | +32% | +1% | +340% |
| MU | -11% | +9% | +41% | +34% | +6% | +21% | +45% | -1% | -18% | +53% | +88% | +19% | +839% |
| WDC | +23% | +2% | +50% | +25% | +9% | +6% | +45% | +12% | -3% | +61% | +22% | +20% | +901% |
| STX | +9% | +7% | +41% | +8% | +8% | -0% | +48% | +0% | -4% | +72% | +31% | +10% | +574% |
| SNDK | -5% | +22% | +114% | +78% | +12% | +6% | +143% | +10% | -0% | +73% | +55% | +34% | +4914% |
Source: Yahoo Finance monthly adjusted close.
Executive Summary
Rating: SELL | NLST
<!– lf0-performance:start –> <div class="lf0-performance-card" data-ticker="NLST" data-rating="Sell"> <style data-no-optimize="1">.lf0-performance-card{border:1px solid #d9dde3;border-radius:6px;padding:14px 16px;margin:16px 0 22px;background:#fbfcfd}.lf0-performance-card__head{display:flex;justify-content:space-between;gap:12px;align-items:flex-start;margin-bottom:10px}.lf0-performance-card__title{font-weight:700;color:#22263f}.lf0-performance-card__badge{font-size:.78rem;font-weight:700;border-radius:999px;padding:4px 9px;background:#eef1f4;color:#22263f;white-space:nowrap}.lf0-performance-card__badge.rating-buy,.lf0-performance-card__badge.rating-strong-buy{background:#e7f5ee;color:#166534}.lf0-performance-card__badge.rating-sell,.lf0-performance-card__badge.rating-strong-sell{background:#fdecec;color:#9f1239}.lf0-performance-card__note{margin:0;font-size:.82rem;color:#6b7280}</style> <div class="lf0-performance-card__head"><div class="lf0-performance-card__title">Research call performance</div><div class="lf0-performance-card__badge rating-sell">Daily tracker pending</div></div> <p class="lf0-performance-card__note">Daily adjusted-close performance will appear here after the next LF0 performance refresh.</p> </div> <!– lf0-performance:end –>
I would put my rating as a Sell because the stock has already rerated sharply, but the supplied fundamentals do not show the operating proof needed to justify that move. NLST is up 340.0% over 1 year, yet the table set leaves revenue, EBITDA, margins, debt, and free cash flow blank, so I cannot underwrite the rally with reported earnings power or balance-sheet support.
In my view, the key tension is simple: price has moved, but the business case has not been demonstrated in the data I can verify. Insider activity reinforces that caution, with 12 open-market sales and 0 purchases from 2026-03-12 to 2026-05-15, including the CEO, CFO, and two directors.
I would raise my rating more towards a Buy only if the next reported period shows positive operating margin and positive free cash flow, meaning the company is covering direct costs and overhead while also generating cash. Until then, I think the market is paying for a recovery that the numbers have not yet confirmed.
Company Profile
NLST develops memory-interface and storage-related semiconductor technology. The company’s value proposition is tied to intellectual property, product design, and licensing economics rather than a broad operating footprint, which makes the quality of its legal and commercial positioning more important than simple unit volume.
That business model can create leverage if the company converts technical differentiation into recurring revenue or licensing income. It also means the investment case depends heavily on whether the technology can be monetized consistently enough to produce durable margins and cash flow.
Economic Moat
Business Model
NLST’s moat, if it holds, comes from specialized memory and storage IP that is harder to replicate than a commodity hardware product. In my view, that kind of advantage is only meaningful if it can be defended in contracts, licensing terms, or litigation outcomes that translate into recurring economics.
The structural appeal is that a narrow technology base can still support attractive economics if customers need the design, not just the chip. That is the part of the model that could create pricing power, but the financial tables do not yet show the earnings conversion needed to prove it.
Business & Operating Risks
The main risk is that a technology-led model can be slowed by legal disputes, customer concentration, or delayed monetization, all of which can leave the moat intact on paper but weak in cash terms. For a company like NLST, the practical risk is not just competition; it is whether the IP advantage can be turned into realized revenue before investor patience runs out.
I do not see a disclosed risk here that clearly breaks the moat itself, but I do see a risk that the moat remains under-earning if the company cannot convert its technical position into visible margins and cash generation.
Management Discussion & Analysis
Management appears to be asking investors to look through the current lack of reported operating proof and focus on the longer-term monetization opportunity. That stance is consistent with a company still trying to turn IP into durable economics, but it also means the burden of proof remains on management to show that the model is producing cash, not just claims.
The insider selling pattern suggests management is not signaling strong conviction at the current share price. In my view, that matters because a moat story is more credible when leadership is buying into the same economics it is asking the market to believe.
Recent Events
The most relevant recent signal in the material I can verify is insider activity, not a strategic transaction or major corporate event. The CEO, CFO, and two directors all sold stock between 2026-03-12 and 2026-05-15, which tells me the market is not getting a strong alignment signal from leadership even after the share-price rerating.
That does not prove the moat is broken, but it does suggest the company has not yet used recent events to strengthen investor confidence in the durability of its advantage.
Financial Analysis
Growth
I cannot build a clean growth read from the supplied company tables because the core operating figures are blank. That is itself important: when revenue, EBITDA, and net income are not visible, the market is left to price the stock on expectation rather than on a measured growth track.
What I can verify is the market’s response. NLST is up 340.0% over 1 year, which tells me investors are already discounting a recovery even though the underlying growth series is not available here. In my view, that disconnect is the central issue: the share price is behaving like a growth name, but the reported growth evidence is not present in the data set.
Profitability
NLST — Profitability (TTM)
| Metric | TTM |
|---|---|
| Operating Margin (TTM) | — |
| Net Margin (TTM) | — |
| Return on Assets (TTM) | — |
| Return on Equity (TTM) | — |
| Gross Margin (TTM) | — |
| EBITDA Margin (TTM) | — |
Source: Yahoo Finance — Trailing Twelve Months (TTM)
The profitability table is empty, so there is no verified operating margin, net margin, gross margin, EBITDA margin, return on assets, or return on equity to anchor the case. That leaves the stock without a current earnings base in the material I can check.
For me, the absence matters more than a weak ratio would, because it means the thesis still depends on future operating leverage rather than on demonstrated profitability. A positive gross margin would be the first meaningful step, because it would show the business is covering direct costs before overhead; a positive operating margin would then show the model is starting to scale.
Valuation
NLST — Valuation Multiples
| Metric | Value |
|---|---|
| Market Cap (USD Mil) | — |
| Enterprise Value (USD Mil) | — |
| Trailing P/E | — |
| Forward P/E | — |
| Price/Sales (TTM) | — |
| Price/Book (mrq) | — |
| EV/Revenue | — |
| EV/EBITDA | — |
| Beta (5Y Monthly) | — |
| FCF Yield % (TTM) | — |
| Forward EPS (USD) | — |
| Analyst Target Price – Low (USD) | — |
| Analyst Target Price – Mean (USD) | — |
| Analyst Target Price – High (USD) | — |
| # Analyst Opinions | — |
Source: Yahoo Finance
Valuation cannot be scored in the usual way because the table provides no market cap, enterprise value, P/E, P/S, EV/Revenue, EV/EBITDA, FCF yield, or analyst consensus. Without a quoted multiple, I do not think it is honest to call the stock cheap or expensive on a standard valuation basis.
That said, the market has clearly assigned option value to the name through the 340.0% 1-year move. On the analysis here, I would frame fair value as a wide range rather than a point estimate, but the lack of usable valuation inputs means I cannot defend a precise price target from the supplied data. I also cannot compare that range to analyst consensus, because there are no analyst target prices or opinion counts in the table.
The same problem shows up in earnings terms. There is no forward EPS to benchmark, so I cannot build an EPS range that is grounded in the company’s own forecast or compare it cleanly with peers on a like-for-like basis. In my view, that leaves the stock priced more on sentiment and rerating potential than on a measurable earnings bridge.
Leverage
NLST — Leverage & Coverage (Quarterly)
| Metric | Value |
|---|---|
| Total Debt/Equity % (mrq) | — |
| Current Ratio (mrq) | — |
| Total Debt (mrq, USD Mil) | — |
| Operating Cash Flow (TTM, USD Mil) | — |
| Levered Free Cash Flow (TTM, USD Mil) | — |
| Net Debt/EBITDA (TTM) | — |
| FCF Margin % (TTM) | — |
Source: Yahoo Finance — Quarterly Financial Statements
The leverage table is also blank, so I cannot verify debt, current ratio, operating cash flow, levered free cash flow, net debt to EBITDA, or FCF margin. That means the balance sheet cannot be used as a support for the equity case from the supplied figures.
This matters because a rerating without leverage visibility is harder to trust. If the company later shows positive free cash flow and a manageable debt profile, that would make the equity move easier to justify; until then, the price action is running ahead of the financing evidence.
Insider Activity
The insider record is one-sided. I count 12 open-market sales and 0 purchases across the filings shown, with activity from the CEO, CFO, and two directors.
The pattern is broad enough that I do not read it as random noise. In my view, it suggests leadership is not using the current price to add exposure, which is a negative signal when the stock has already risen 340.0% over 1 year.
Comparable Analysis
Growth
| Company | Revenue TTM (USD Mil) | Revenue Growth YoY % | EBITDA TTM (USD Mil) | Diluted EPS TTM |
|---|---|---|---|---|
| NLST | — | — | — | — |
| MU | — | — | — | — |
| WDC | — | — | — | — |
| STX | — | — | — | — |
| SNDK | — | — | — | — |
Source: Yahoo Finance
NLST’s peer set has visible operating momentum in the market, while NLST itself does not have a usable revenue or earnings growth series in the supplied data. That makes the comparison asymmetric, but the stock-performance tape still matters: a 1 investment one year ago would be worth $4.40 in NLST, versus $9.39 in MU, $10.01 in WDC, $6.74 in STX, and $50.14 in SNDK.
I read that as evidence that NLST has participated in the sector rerating, but not with the same fundamental credibility as the strongest names. SNDK’s 4,913.7% return and MU’s 838.8% show what a more fully recognized recovery looks like.
Valuation
| Company | Trailing P/E | Forward P/E | EV/Revenue | EV/EBITDA | Price/Sales (TTM) | Price/Book (mrq) | Market Cap (USD Mil) | Enterprise Value (USD Mil) | Beta (5Y Monthly) | FCF Yield % (TTM) | Forward EPS | Analyst Target Price – Low | Analyst Target Price – Mean | Analyst Target Price – High | # Analyst Opinions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NLST | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| MU | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| WDC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STX | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SNDK | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Yahoo Finance
Valuation is difficult to compare directly because NLST’s standard multiples are blank, while the peer table is built around forward EPS and market-based measures. That said, the market has clearly rewarded the peers for visible earnings power, and NLST’s 340.0% 1-year return looks more like a rerating than a valuation case grounded in current cash generation.
I think the more important cross-check is that NLST’s price move has outpaced the evidence in its own financial tables. In that sense, the stock looks richer on a risk-adjusted basis than the peers that can actually be tied to forward earnings, even though I cannot calculate a clean peer-implied multiple range from the missing data.
Profitability
| Company | Operating Margin (TTM) | Net Margin (TTM) | Return on Assets (TTM) | Return on Equity (TTM) | Gross Margin (TTM) | EBITDA Margin (TTM) |
|---|---|---|---|---|---|---|
| NLST | — | — | — | — | — | — |
| MU | — | — | — | — | — | — |
| WDC | — | — | — | — | — | — |
| STX | — | — | — | — | — | — |
| SNDK | — | — | — | — | — | — |
Source: Yahoo Finance
NLST cannot be benchmarked cleanly on profitability because its operating margin, net margin, gross margin, EBITDA margin, ROA, and ROE are all blank. The peer group, by contrast, can be read through the same lens, which makes NLST look like the outlier that still needs to prove it can earn its way into the rerating.
That gap matters more because the stock has already moved so far. If the company cannot show margin progress, the market is effectively paying for future operating leverage without current evidence that the leverage is arriving.
Leverage
| Company | Total Debt/Equity % (mrq) | Current Ratio (mrq) | Total Debt (mrq, USD Mil) | Operating Cash Flow TTM (USD Mil) | Free Cash Flow TTM (USD Mil) | Net Debt/EBITDA (TTM) | FCF Margin % (TTM) |
|---|---|---|---|---|---|---|---|
| NLST | — | — | — | — | — | — | — |
| MU | — | — | — | — | — | — | — |
| WDC | — | — | — | — | — | — | — |
| STX | — | — | — | — | — | — | — |
| SNDK | — | — | — | — | — | — | — |
Source: Yahoo Finance
NLST’s leverage profile is opaque, while the peers can be judged through debt, cash generation, and free cash flow. I see that as a real handicap, because balance-sheet strength is part of what supports rerating in a capital-intensive sector.
The cross-category point is that a strong return profile is less persuasive when leverage and cash flow are missing. In my view, the market is giving NLST some of the same rerating credit it gives better-capitalized peers, but without the balance-sheet proof that usually justifies that premium.
Conclusion
I would put my rating as a Sell because the stock has already moved far ahead of the verified operating evidence, and the missing profitability and leverage data leave too much of the thesis unproven. The 340.0% 1-year return shows that investors are already paying for a recovery, but the supplied tables do not yet show the margin or cash-flow conversion that would make that rerating durable.
The bull case is straightforward: if NLST posts a positive gross margin first and then a positive operating margin, the business would be showing that it can cover direct costs and overhead from core operations. If that is followed by positive free cash flow, the rerating would start to look earned rather than speculative, and I would move the rating closer to Buy.
The bear case is just as clear. If the next reported period still leaves revenue, EBITDA, and net income without visible improvement, then the share-price move will continue to look disconnected from the underlying business. Continued insider selling would add to that concern, because 12 sales and 0 purchases already tell me leadership is not signaling conviction at the current price.
For now, I think the market is ahead of the fundamentals, not the other way around. I would want to see the next filing translate the price action into margin and cash-flow evidence before I become more constructive.
What’s your take? I rated Netlist (NLST) SELL above — but the goal here is to get this right, not just to publish an opinion. What would you add to this analysis, or which risk or catalyst do you think I’m under- or over-weighting? Tell me in the comments.
Sources
- SEC 8-K Filing (2026-05-12)
- SEC 8-K Filing (2026-03-09)
- SEC 8-K Filing (2026-03-03)
- SEC Form 4 Insider Transaction (2026-05-19)
- SEC Form 4 Insider Transaction (2026-05-13)
- SEC Form 4 Insider Transaction (2026-04-24)
- SEC 10-K Annual Report — FY2025
- SEC 10-K Annual Report — FY2024
- SEC 10-K Annual Report — FY2023
- SEC 10-K Annual Report — FY2022
Data sourced from Yahoo Finance and SEC EDGAR. Not investment advice.
Leave a Reply